Year |
Citation |
Score |
2020 |
Wilkes MC, Siva K, Varetti G, Mercado J, Wentworth EP, Perez C, Saxena M, Kam S, Kapur S, Chen J, Narla A, Glader B, Lin S, Serrano M, Flygare J, ... Sakamoto KM, et al. Metformin-induced suppression of NLK improves erythropoiesis in pre-clinical models of Diamond Blackfan Anemia through induction of miR-26a. Experimental Hematology. PMID 32926965 DOI: 10.1016/J.Exphem.2020.09.187 |
0.313 |
|
2020 |
Chae HD, Dutta R, Tiu B, Hoff FW, Accordi B, Serafin V, Youn M, Huang M, Sumarsono N, Davis KL, Lacayo NJ, Pigazzi M, Horton TM, Kornblau SM, Sakamoto KM. RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 11: 2387-2403. PMID 32637030 DOI: 10.18632/Oncotarget.27630 |
0.384 |
|
2020 |
Wilkes MC, Siva K, Chen J, Varetti G, Youn MY, Chae H, Ek F, Olsson R, Lundbäck T, Dever DP, Nishimura T, Narla A, Glader B, Nakauchi H, Porteus MH, ... ... Sakamoto KM, et al. Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase. Nature Communications. 11: 3344. PMID 32620751 DOI: 10.1038/S41467-020-17100-Z |
0.382 |
|
2020 |
Wojcicki AV, Kasowski MM, Sakamoto KM, Lacayo N. Metabolomics in acute myeloid leukemia. Molecular Genetics and Metabolism. PMID 32457018 DOI: 10.1016/J.Ymgme.2020.05.005 |
0.314 |
|
2020 |
Huang M, Zeki J, Sumarsono N, Coles GL, Taylor JS, Danzer E, Bruzoni M, Hazard FK, Lacayo NJ, Sakamoto KM, Dunn JCY, Spunt SL, Chiu B. EPIGENETIC TARGETING OF TERT-ASSOCIATED GENE EXPRESSION SIGNATURE IN HUMAN NEUROBLASTOMA WITH TERT OVEREXPRESSION. Cancer Research. PMID 31900258 DOI: 10.1158/0008-5472.Can-19-2560 |
0.387 |
|
2019 |
Youn M, Huang H, Chen C, Kam S, Wilkes MC, Chae HD, Sridhar KJ, Greenberg PL, Glader B, Narla A, Lin S, Sakamoto KM. MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways. Blood Advances. 3: 2751-2763. PMID 31540902 DOI: 10.1182/Bloodadvances.2019000537 |
0.309 |
|
2019 |
Chae HD, Cox N, Capolicchio S, Lee JW, Horikoshi N, Kam S, Ng AA, Edwards J, Butler TL, Chan J, Lee Y, Potter G, Capece MC, Liu CW, Wakatsuki S, ... ... Sakamoto KM, et al. SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway. Bioorganic & Medicinal Chemistry Letters. PMID 31253529 DOI: 10.1016/J.Bmcl.2019.06.023 |
0.357 |
|
2019 |
Wilkes MC, Mercado JD, Saxena M, Chen J, Siva K, Chae H, Youn M, Wentworth EP, Jung K, Sathianathen R, Patel H, Glader B, Narla A, Repellin CE, Gazda HT, ... ... Sakamoto KM, et al. Pharmacological Inhibition of Nemo-like Kinase Rescues mTOR-Mediated Translation and Primes Progenitors for Leucine-Stimulated Erythroid Expansion in Pre-Clinical Models of Diamond Blackfan Anemia Blood. 134: 455-455. DOI: 10.1182/Blood-2019-129570 |
0.421 |
|
2019 |
Wilkes M, Mercado J, Saxena M, Chen J, Siva K, Varetti G, Chae H, Youn M, Gazda H, Serrano M, Flygare J, Sakamoto K. 3182 – PHARMACOLOGICAL INHIBITION OF NEMO-LIKE KINASE RESCUES MTOR-MEDIATED TRANSLATION AND ERYTHROPOIESIS IN PRE-CLINICAL MODELS OF DIAMOND BLACKFAN ANEMIA Experimental Hematology. 76: e5-e6. DOI: 10.1016/J.Exphem.2019.09.019 |
0.374 |
|
2018 |
Duque-Afonso J, Lin CH, Han K, Morgens DW, Jeng EE, Weng Z, Jeong J, Wong SHK, Zhu L, Wei MC, Chae HD, Schrappe M, Cario G, Duyster J, Sakamoto KM, et al. CBP modulates sensitivity to dasatinib in pre-BCR+ acute lymphoblastic leukemia. Cancer Research. PMID 30262461 DOI: 10.1158/0008-5472.Can-18-1703 |
0.346 |
|
2018 |
Danilova N, Wilkes M, Bibikova E, Youn MY, Sakamoto KM, Lin S. Innate immune system activation in zebrafish and cellular models of Diamond Blackfan Anemia. Scientific Reports. 8: 5165. PMID 29581525 DOI: 10.1038/S41598-018-23561-6 |
0.352 |
|
2018 |
Chae HD, Cox N, Dahl GV, Lacayo NJ, Davis KL, Capolicchio S, Smith M, Sakamoto KM. Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways. Oncotarget. 9: 4301-4317. PMID 29435104 DOI: 10.18632/Oncotarget.23794 |
0.466 |
|
2018 |
Chae H, Murphy LC, Donato M, Lee AG, Sweet-Cordero EA, Abidi P, Bittencourt H, Lacayo NJ, Dahl GVH, Aftandilian C, Davis KL, Huang M, Sumarsono N, Redell M, Fu CH, ... ... Sakamoto KM, et al. Comparison of the Transcriptomic Signature of Pediatric Vs. Adult CML and Normal Bone Marrow Stem Cells Blood. 132: 4246-4246. DOI: 10.1182/Blood-2018-99-119974 |
0.369 |
|
2018 |
Wilkes MC, Chen J, Siva K, Veretti G, Dever DP, Youn M, Chae H, Mercado JD, Saxena M, Narla A, Glader B, Porteus M, Repellin CE, Gazda HT, Serrano M, ... ... Sakamoto KM, et al. Pharmacological Inhibition of Nlk (Nemo-like Kinase) Rescues Erythropoietic Defects in Pre-Clinical Models of Diamond Blackfan Anemia Blood. 132: 754-754. DOI: 10.1182/Blood-2018-99-119954 |
0.407 |
|
2018 |
Wilkes MC, Takasaki K, Youn M, Chae H, Narla A, Sakamoto KM. Chromatin Organization By SATB1 Regulates HSP70 Induction in Early Erythropoiesis and Lost in Diamond Blackfan Anemia Blood. 132: 2591-2591. DOI: 10.1182/Blood-2018-99-119729 |
0.379 |
|
2018 |
Youn M, Huang H, Chen C, Kam S, Wilkes MC, Chae H, Narla A, Lin S, Sakamoto KM. MMP9 Inhibition Rescues the Erythroid Defect in RPS14-Deficient Del(5q) MDS Models Blood. 132: 756-756. DOI: 10.1182/Blood-2018-99-117508 |
0.337 |
|
2018 |
Aftandilian C, Sakamoto KM, Davis KL, Dahl GVH, Lacayo NJ. Chromatin Remodeling Therapy and Capizzi Methotrexate in Treatment-Related MDS/AML Blood. 132: 5222-5222. DOI: 10.1182/Blood-2018-99-110481 |
0.312 |
|
2017 |
Wilkes MC, Repellin CE, Sakamoto KM. Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis. Molecular Genetics and Metabolism. PMID 28757239 DOI: 10.1016/J.Ymgme.2017.07.008 |
0.302 |
|
2017 |
Sakamoto KM. Lost in translation: RP and GATA1 mutations in DBA. Blood. 129: 3048-3049. PMID 28596438 DOI: 10.1182/Blood-2017-04-778969 |
0.364 |
|
2017 |
Youn M, Wang N, LaVasseur C, Bibikova E, Kam S, Glader B, Sakamoto KM, Narla A. Loss of FOXM1 promotes erythropoiesis through increased proliferation of erythroid progenitors. Haematologica. PMID 28154085 DOI: 10.3324/Haematol.2016.156257 |
0.438 |
|
2017 |
Wilkes MC, Lee JW, Kudaravalli S, Narla A, Glader B, Sakamoto KM. Nemo-like Kinase Hyper-Activated in Erythroid Progenitors in Models of Diamond Blackfan Anemia Blood. 130: 78-78. DOI: 10.1182/Blood.V130.Suppl_1.78.78 |
0.422 |
|
2016 |
François S, Sen N, Mitton B, Xiao X, Sakamoto KM, Arvin A. Varicella-Zoster Virus Activates CREB and Inhibition of the pCREB-p300/CBP- Interaction Inhibits Viral Replication in vitro and Skin Pathogenesis in vivo. Journal of Virology. PMID 27440893 DOI: 10.1128/Jvi.00920-16 |
0.32 |
|
2016 |
Dutta R, Tiu B, Sakamoto KM. CBP/p300 acetyltransferase activity in hematologic malignancies. Molecular Genetics and Metabolism. PMID 27380996 DOI: 10.1016/J.Ymgme.2016.06.013 |
0.365 |
|
2016 |
Ear J, Hsueh J, Nguyen M, Zhang Q, Sung V, Chopra R, Sakamoto KM, Lin S. A Zebrafish Model of 5q-Syndrome Using CRISPR/Cas9 Targeting RPS14 Reveals a p53-Independent and p53-Dependent Mechanism of Erythroid Failure. Journal of Genetics and Genomics = Yi Chuan Xue Bao. PMID 27216296 DOI: 10.1016/J.Jgg.2016.03.007 |
0.325 |
|
2016 |
Mitton B, Chae HD, Hsu K, Dutta R, Aldana-Masangkay G, Ferrari R, Davis K, Tiu BC, Kaul A, Lacayo N, Dahl G, Xie F, Li BX, Breese MR, Landaw EM, ... ... Sakamoto KM, et al. Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. Leukemia. PMID 27211267 DOI: 10.1038/Leu.2016.139 |
0.477 |
|
2016 |
Huang W, Luan CH, Hjort EE, Bei L, Mishra R, Sakamoto KM, Platanias LC, Eklund EA. The role of Fas-associated phosphatase 1 in leukemia stem cell-persistence during tyrosine kinase inhibitor-treatment of chronic myeloid leukemia. Leukemia. PMID 26984787 DOI: 10.1038/Leu.2016.66 |
0.364 |
|
2016 |
Mitton B, Hsu K, Dutta R, Tiu BC, Cox N, McLure KG, Chae HD, Smith M, Eklund EA, Solow-Cordero DE, Sakamoto KM. Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters. Oncotarget. PMID 26840025 DOI: 10.18632/Oncotarget.7085 |
0.392 |
|
2016 |
Wilkes M, Bibikova E, Youn M, Lee AG, Eskin A, Nelson S, Glader B, Narla A, Sakamoto KM. Role of Mir-34 Upregulation in Disruption of c-Myc, c-Myb and NOTCH Signaling in Diamond-Blackfan Anemia Blood. 128: 3895-3895. DOI: 10.1182/Blood.V128.22.3895.3895 |
0.34 |
|
2016 |
Dutta R, Castellanos M, Tiu B, Chae H, Davis KL, Sakamoto KM. RSK Inhibition Suppresses AML Proliferation through Activation of DNA Damage Pathways and S Phase Arrest Blood. 128: 2894-2894. DOI: 10.1182/Blood.V128.22.2894.2894 |
0.45 |
|
2016 |
Chae H, Cox N, Zhang X, Lee JW, Morgens D, Bassik MC, Smith M, Sakamoto KM. The Salicylamide Derivative, Niclosamide, Inhibits CREB Function in Acute Myeloid Leukemia Cells In Vitro and In Vivo Blood. 128: 1647-1647. DOI: 10.1182/Blood.V128.22.1647.1647 |
0.476 |
|
2015 |
Rankin EB, Narla A, Park JK, Lin S, Sakamoto KM. Biology of the bone marrow microenvironment and myelodysplastic syndromes. Molecular Genetics and Metabolism. PMID 26210353 DOI: 10.1016/J.Ymgme.2015.07.004 |
0.341 |
|
2015 |
Kim PG, Nakano H, Das PP, Chen MJ, Rowe RG, Chou SS, Ross SJ, Sakamoto KM, Zon LI, Schlaeger TM, Orkin SH, Nakano A, Daley GQ. Flow-induced protein kinase A-CREB pathway acts via BMP signaling to promote HSC emergence. The Journal of Experimental Medicine. 212: 633-48. PMID 25870201 DOI: 10.1084/Jem.20141514 |
0.388 |
|
2015 |
Chae HD, Mitton B, Lacayo NJ, Sakamoto KM. Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA. Leukemia. 29: 1379-89. PMID 25541153 DOI: 10.1038/Leu.2014.350 |
0.426 |
|
2015 |
Sakamoto KM, Grant S, Saleiro D, Crispino JD, Hijiya N, Giles F, Platanias L, Eklund EA. Targeting novel signaling pathways for resistant acute myeloid leukemia. Molecular Genetics and Metabolism. 114: 397-402. PMID 25533111 DOI: 10.1016/J.Ymgme.2014.11.017 |
0.336 |
|
2015 |
Youn M, Bibikova E, LaVasseur C, Glader B, Sakamoto K, Narla A. Loss of FoxM1 Promotes Erythroid Differentiation through Increased Proliferation of Erythroid Progenitors Blood. 126: 933-933. DOI: 10.1182/Blood.V126.23.933.933 |
0.412 |
|
2015 |
Dutta R, Tiu B, Kaul A, Mitton B, Sakamoto KM. CREB Increases Chemotherapy Resistance through Regulation of the DNA Damage Repair Pathway in AML Cells Blood. 126: 1390-1390. DOI: 10.1182/Blood.V126.23.1390.1390 |
0.389 |
|
2014 |
Bibikova E, Youn MY, Danilova N, Ono-Uruga Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S, Sakamoto KM. TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors. Blood. 124: 3791-8. PMID 25270909 DOI: 10.1182/Blood-2014-06-584656 |
0.351 |
|
2014 |
Danilova N, Bibikova E, Covey TM, Nathanson D, Dimitrova E, Konto Y, Lindgren A, Glader B, Radu CG, Sakamoto KM, Lin S. The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia. Disease Models & Mechanisms. 7: 895-905. PMID 24812435 DOI: 10.1242/Dmm.015495 |
0.344 |
|
2014 |
Chae H, Mitton B, Sakamoto K. CREB Regulates Cell Cycle Progression through RFC3-PCNA Axis in Acute Myeloid Leukemia Blood. 124: 881-881. DOI: 10.1182/Blood.V124.21.881.881 |
0.463 |
|
2014 |
Youn M, Bibikova E, Danilova N, Ono-Uruga Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S, Sakamoto K. RPS19 Deficiency Leads to GATA1 Downregulation through TNF-Mediated p38 MAPK Activation Blood. 124: 2934-2934. DOI: 10.1182/Blood.V124.21.2934.2934 |
0.396 |
|
2014 |
Mitton B, Dutta R, Hsu Y, Sakamoto K. The Role of pp90rsk-Mediated CREB Phosphorylation in Acute Myelogenous Leukemia Blood. 124: 2229-2229. DOI: 10.1182/Blood.V124.21.2229.2229 |
0.449 |
|
2014 |
Mitra SS, Gholamin S, Volkmer J, Feroze A, Liu J, Achrol A, Wang L, Sayles L, Zhang M, Sakamoto K, Monje-Deisseroth M, Cho Y, Sweet-Cordero A, Majeti R, Cheshier S, et al. Abstract PR12: Overcoming immune evasion in pediatric hematologic and solid tumor malignancies: A preclinical study using a humanized anti-CD47 antibody Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Pr12 |
0.325 |
|
2013 |
Wen AY, Landaw EM, Ochoa R, Cho M, Chao A, Lawson G, Sakamoto KM. Increased abscess formation and defective chemokine regulation in CREB transgenic mice. Plos One. 8: e55866. PMID 23405224 DOI: 10.1371/Journal.Pone.0055866 |
0.347 |
|
2013 |
Pigazzi M, Manara E, Bresolin S, Tregnago C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, Sakamoto KM, Basso G. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. Haematologica. 98: 602-10. PMID 23100280 DOI: 10.3324/Haematol.2012.070664 |
0.359 |
|
2013 |
Mitton B, Dutta R, Hsu Y, Ochoa R, Landaw E, Xiao X, Sakamoto K. The pp90rsk-CREB Signaling Pathway Regulates Apoptosis In Acute Myelogenous Leukemia Blood. 122: 3801-3801. DOI: 10.1182/Blood.V122.21.3801.3801 |
0.443 |
|
2013 |
Chae H, Sakamoto K. Replication Factor C3 Is a Direct Target Of CREB, Promotes G1/S Transition Of Acute Myeloid Leukemia Cells, and Increases Hematopoietic Stem/Progenitor Cell Self-Renewal Blood. 122: 3754-3754. DOI: 10.1182/Blood.V122.21.3754.3754 |
0.452 |
|
2013 |
Konto-Ghiorghi Y, Bibikova E, Glader B, Narla A, Sakamoto K. Transcriptional Profiling and Cytokine Signaling In The Pathogenesis Of Diamond-Blackfan Anemia Blood. 122: 2474-2474. DOI: 10.1182/Blood.V122.21.2474.2474 |
0.358 |
|
2013 |
Danilova N, Elena B, Covey T, Nathanson D, Dimitrova E, Anne L, Glader B, Radu C, Sakamoto K, Lin S. Defective Nucleotide Metabolism Contributes To p53 Activation In Diamond-Blackfan Anemia Blood. 122: 1225-1225. DOI: 10.1182/Blood.V122.21.1225.1225 |
0.389 |
|
2012 |
Sandoval S, Kraus C, Cho EC, Cho M, Bies J, Manara E, Accordi B, Landaw EM, Wolff L, Pigazzi M, Sakamoto KM. Sox4 cooperates with CREB in myeloid transformation. Blood. 120: 155-65. PMID 22627767 DOI: 10.1182/Blood-2011-05-357418 |
0.455 |
|
2011 |
Cho EC, Mitton B, Sakamoto KM. CREB and leukemogenesis. Critical Reviews in Oncogenesis. 16: 37-46. PMID 22150306 DOI: 10.1615/Critrevoncog.V16.I1-2.50 |
0.386 |
|
2011 |
Mitton B, Cho EC, Aldana-Masangkay GI, Sakamoto KM. The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies. Leukemia & Lymphoma. 52: 2057-63. PMID 22023600 DOI: 10.3109/10428194.2011.584994 |
0.428 |
|
2011 |
Sakamoto KM. Editorial: granulopoiesis versus monopoiesis: a consequence of transcription factors dancing with the right partners. Journal of Leukocyte Biology. 90: 637-8. PMID 21965310 DOI: 10.1189/Jlb.0411187 |
0.304 |
|
2011 |
Aldana-Masangkay GI, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Hsieh YT, Kim YM, Lomenick B, Okemoto K, Landaw EM, Wang D, Mazitschek R, Bradner JE, Sakamoto KM. Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells. Leukemia & Lymphoma. 52: 1544-55. PMID 21699378 DOI: 10.3109/10428194.2011.570821 |
0.411 |
|
2011 |
Hernandez-Davies JE, Zape JP, Landaw EM, Tan X, Presnell A, Griffith D, Heinrich MC, Glaser KB, Sakamoto KM. The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway. Molecular Cancer Therapeutics. 10: 949-59. PMID 21471285 DOI: 10.1158/1535-7163.Mct-10-0904 |
0.37 |
|
2011 |
Danilova N, Sakamoto KM, Lin S. Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects. British Journal of Haematology. 152: 217-28. PMID 21114664 DOI: 10.1111/J.1365-2141.2010.08396.X |
0.355 |
|
2011 |
Aldana-Masangkay GI, Sakamoto KM. The role of HDAC6 in cancer. Journal of Biomedicine & Biotechnology. 2011: 875824. PMID 21076528 DOI: 10.1155/2011/875824 |
0.366 |
|
2011 |
Aldana-Masangkay GI, Mitton B, Ikeda AK, Yamada K, Li B, Fan Q, Landaw E, Xiao X, Sakamoto KM. A Small Molecule Inhibitor Targeting CREB and CBP Inhibits Proliferation of AML Cells In Vitro and In Vivo, Blood. 118: 3607-3607. DOI: 10.1182/Blood.V118.21.3607.3607 |
0.445 |
|
2011 |
Sandoval S, Cho M, Kraus C, Cho E, Wolff L, Sakamoto KM. Sox4 and CREB Cooperate in Myeloid Transformation, Blood. 118: 3452-3452. DOI: 10.1182/Blood.V118.21.3452.3452 |
0.386 |
|
2011 |
Danilova N, Sakamoto KM, Lin S. Beneficial Effects of Nucleoside Treatment in Zebrafish Models of Diamond Blackfan Anemia Deficient in Ribosomal Proteins L11 or S19, Blood. 118: 3439-3439. DOI: 10.1182/Blood.V118.21.3439.3439 |
0.361 |
|
2011 |
Bibikova E, Lin S, Sakamoto KM. MiR34a Contributes to Defective Erythropoiesis in RPS19 Insufficient Hematopoietic Stem Cells Blood. 118: 2404-2404. DOI: 10.1182/Blood.V118.21.2404.2404 |
0.425 |
|
2010 |
Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S, Jones E, McGovern K, Watkins DN, Sakamoto KM, Matsui W. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. Plos One. 5: e15262. PMID 21203400 DOI: 10.1371/Journal.Pone.0015262 |
0.362 |
|
2010 |
Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. Journal of Immunology (Baltimore, Md. : 1950). 185: 6413-9. PMID 21084670 DOI: 10.4049/Jimmunol.1001829 |
0.358 |
|
2010 |
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nature Genetics. 42: 794-800. PMID 20694012 DOI: 10.1038/Ng.641 |
0.339 |
|
2010 |
Wu WK, Sakamoto KM, Milani M, Aldana-Masankgay G, Fan D, Wu K, Lee CW, Cho CH, Yu J, Sung JJ. Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 87-92. PMID 20462785 DOI: 10.1016/J.Drup.2010.04.003 |
0.368 |
|
2010 |
Xiao X, Li BX, Mitton B, Ikeda A, Sakamoto KM. Targeting CREB for cancer therapy: friend or foe. Current Cancer Drug Targets. 10: 384-91. PMID 20370681 DOI: 10.2174/156800910791208535 |
0.413 |
|
2010 |
Ikeda AK, Judelson DR, Federman N, Glaser KB, Landaw EM, Denny CT, Sakamoto KM. ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways. Molecular Cancer Therapeutics. 9: 653-60. PMID 20197394 DOI: 10.1158/1535-7163.Mct-09-0812 |
0.389 |
|
2010 |
Sakamoto KM. Protacs for treatment of cancer. Pediatric Research. 67: 505-8. PMID 20075761 DOI: 10.1203/Pdr.0B013E3181D35017 |
0.347 |
|
2010 |
Manara E, Baron E, Beghin A, Tregnago C, Giarin E, Sakamoto KM, Pigazzi M, Basso G. MiR-34b Promoter Methylation and Regulation of CREB Expression In Myeloid Transformation Blood. 116: 538-538. DOI: 10.1182/Blood.V116.21.538.538 |
0.304 |
|
2010 |
Tasian SK, Doral MY, Wood BL, Borowitz MJ, Collins-Underwood JR, Harvey RC, Sakamoto KM, Willman CL, Hunger SP, Mullighan CG, Loh ML. Thymic Stromal Lymphopoietin Stimulation of Pediatric Acute Lymphoblastic Leukemias with CRLF2 Alterations Induces JAK/STAT and PI3K Phosphosignaling Blood. 116: 410-410. DOI: 10.1182/Blood.V116.21.410.410 |
0.39 |
|
2010 |
Mitton B, Ikeda A, Yamada K, Li B, Fan Q, Landaw E, Xiao X, Sakamoto KM. Inhibitor of the CREB Proto-Oncogene Suppresses AML Cell Proliferation and Induces Apoptosis In Vitro and In Vivo Blood. 116: 3270-3270. DOI: 10.1182/Blood.V116.21.3270.3270 |
0.452 |
|
2010 |
Danilova N, Sakamoto KM, Lin S. Characterization of p53-Dependent Pathways In RPL11 Mutant Zebrafish Blood. 116: 2227-2227. DOI: 10.1182/Blood.V116.21.2227.2227 |
0.424 |
|
2010 |
Simms-Waldrip T, Cho MY, Dorshkind K, Sakamoto KM. CREB Regulates Early Myelopoiesis and Myeloid Engraftment. Blood. 116: 1452-1452. DOI: 10.1182/Blood.V116.21.1452.1452 |
0.404 |
|
2009 |
Sandoval S, Pigazzi M, Sakamoto KM. CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis. Advances in Hematology. 2009: 634292. PMID 19960054 DOI: 10.1155/2009/634292 |
0.436 |
|
2009 |
Sakamoto KM, Frank DA. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2583-7. PMID 19351775 DOI: 10.1158/1078-0432.Ccr-08-1137 |
0.423 |
|
2008 |
Danilova N, Sakamoto KM, Lin S. p53 family in development. Mechanisms of Development. 125: 919-31. PMID 18835440 DOI: 10.1016/J.Mod.2008.09.003 |
0.309 |
|
2008 |
Pellegrini M, Cheng JC, Voutila J, Judelson D, Taylor J, Nelson SF, Sakamoto KM. Expression profile of CREB knockdown in myeloid leukemia cells. Bmc Cancer. 8: 264. PMID 18801183 DOI: 10.1186/1471-2407-8-264 |
0.443 |
|
2008 |
Rodriguez-Gonzalez A, Cyrus K, Salcius M, Kim K, Crews CM, Deshaies RJ, Sakamoto KM. Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer. Oncogene. 27: 7201-11. PMID 18794799 DOI: 10.1038/Onc.2008.320 |
0.59 |
|
2008 |
Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Molecular Cancer Therapeutics. 7: 2142-51. PMID 18645024 DOI: 10.1158/1535-7163.Mct-08-0005 |
0.314 |
|
2008 |
Danilova N, Sakamoto KM, Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood. 112: 5228-37. PMID 18515656 DOI: 10.1182/Blood-2008-01-132290 |
0.358 |
|
2008 |
Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM. The aggresome pathway as a target for therapy in hematologic malignancies. Molecular Genetics and Metabolism. 94: 283-6. PMID 18472289 DOI: 10.1016/J.Ymgme.2008.03.012 |
0.356 |
|
2008 |
Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Research. 68: 2557-60. PMID 18413721 DOI: 10.1158/0008-5472.Can-07-5989 |
0.372 |
|
2008 |
Cheng JC, Kinjo K, Judelson DR, Chang J, Wu WS, Schmid I, Shankar DB, Kasahara N, Stripecke R, Bhatia R, Landaw EM, Sakamoto KM. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood. 111: 1182-92. PMID 17975014 DOI: 10.1182/Blood-2007-04-083600 |
0.457 |
|
2008 |
Esparza SD, Chang J, Shankar DB, Zhang B, Nelson SF, Sakamoto KM. CREB regulates Meis1 expression in normal and malignant hematopoietic cells. Leukemia. 22: 665-7. PMID 17805329 DOI: 10.1038/Sj.Leu.2404933 |
0.389 |
|
2008 |
Sakamoto KM. The Role of GM-CSF Signaling and CREB in Myeloid Proliferation and Survival. Blood. 112: sci-33-sci-33. DOI: 10.1182/Blood.V112.11.Sci-33.Sci-33 |
0.473 |
|
2008 |
Danilova N, Morimoto K, Sakamoto KM, Lin S. Aberrant p53 Signaling Pathways in RPL11 Mutant Zebrafish Blood. 112: 37-37. DOI: 10.1182/Blood.V112.11.37.37 |
0.38 |
|
2008 |
Hernandez JE, Zape J, Glaser K, Landaw E, Fu C, Sakamoto KM. Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Suppresses Proliferation of Ba/F3 FLT-3 ITD Mutant Cells in Vitro and in Vivo through Inhibition of FLT3 and AKT. Blood. 112: 1938-1938. DOI: 10.1182/Blood.V112.11.1938.1938 |
0.378 |
|
2008 |
Rodriguez-Gonzalez A, Simms-Waldrip T, Ikeda AK, Lin T, Lomenick B, Aldana-Masangkay G, Mazitschek R, Bradner J, Fu C, Sakamoto KM. Tubacin, An Inhibitor of HDAC6, Induces Apoptosis of Acute Lymphoblastic Leukemia Cells in Vitro and in Vivo through a Na+/K+ATPase-Dependent Pathway. Blood. 112: 1923-1923. DOI: 10.1182/Blood.V112.11.1923.1923 |
0.402 |
|
2008 |
Sakamoto K, Rodriguez-Gonzalez A, Cyrus K, Kim K, Crews C, Deshaies R. 39 INVITED Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer European Journal of Cancer Supplements. 6: 16. DOI: 10.1016/S1359-6349(08)71971-2 |
0.518 |
|
2007 |
Yang Z, Jiang H, Zhao F, Shankar DB, Sakamoto KM, Zhang MQ, Lin S. A highly conserved regulatory element controls hematopoietic expression of GATA-2 in zebrafish. Bmc Developmental Biology. 7: 97. PMID 17708765 DOI: 10.1186/1471-213X-7-97 |
0.369 |
|
2007 |
Cheng JC, Esparza S, Sandoval S, Shankar D, Fu C, Sakamoto KM. Potential role of CREB as a prognostic marker in acute myeloid leukemia. Future Oncology (London, England). 3: 475-80. PMID 17661722 DOI: 10.2217/14796694.3.4.475 |
0.417 |
|
2007 |
Shankar DB, Li J, Tapang P, Owen McCall J, Pease LJ, Dai Y, Wei RQ, Albert DH, Bouska JJ, Osterling DJ, Guo J, Marcotte PA, Johnson EF, Soni N, Hartandi K, ... ... Sakamoto KM, et al. ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Blood. 109: 3400-8. PMID 17209055 DOI: 10.1182/Blood-2006-06-029579 |
0.381 |
|
2007 |
Ikeda AK, Judelson D, Li J, Wei RQ, Tapang P, Davidsen SK, Albert DH, Glaser KB, Fu C, Sakamoto KM. Targeting FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia. Blood. 110: 912-912. DOI: 10.1182/Blood.V110.11.912.912 |
0.404 |
|
2007 |
Danilova N, Sakamoto K, Lin S. Imbalance of p53 Family Members as a New Target of Therapeutics for Treatment of Diamond Blackfan Anemia. Blood. 110: 423-423. DOI: 10.1182/Blood.V110.11.423.423 |
0.387 |
|
2007 |
Rodriguez-Gonzalez A, Ch’ng J, Ikeda AK, Lin T, Bahrami B, Mazitschek R, Bradner JE, Fu C, Sakamoto KM. Targeting Histone Deacetylase 6 and the Aggresome Pathway in Acute Lymphoblastic Leukemia Cells. Blood. 110: 1602-1602. DOI: 10.1182/Blood.V110.11.1602.1602 |
0.443 |
|
2007 |
Hernandez JE, Li J, Wei R, Tapang P, Davidsen SK, Albert DH, Marcotte PA, Glaser KB, Fu C, Sakamoto KM. Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Inhibition of Proliferation of Ba/F3 FLT-3 ITD Mutant Cells. Blood. 110: 1589-1589. DOI: 10.1182/Blood.V110.11.1589.1589 |
0.381 |
|
2007 |
Cheng JC, Judelson D, Kinjo K, Chang J, Landaw E, Sakamoto KM. CREB Plays a Critical Role in the Regulation of Normal and Malignant Hematopoiesis. Blood. 110: 1224-1224. DOI: 10.1182/Blood.V110.11.1224.1224 |
0.465 |
|
2006 |
Morimoto K, Lin S, Sakamoto K. The functions of RPS19 and their relationship to Diamond-Blackfan anemia: a review. Molecular Genetics and Metabolism. 90: 358-62. PMID 17178250 DOI: 10.1016/J.Ymgme.2006.11.004 |
0.316 |
|
2006 |
Ikeda A, Shankar DB, Watanabe M, Tamanoi F, Moore TB, Sakamoto KM. Molecular targets and the treatment of myeloid leukemia. Molecular Genetics and Metabolism. 88: 216-24. PMID 16678459 DOI: 10.1016/J.Ymgme.2006.03.011 |
0.343 |
|
2006 |
Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM. FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells (Dayton, Ohio). 24: 1174-84. PMID 16410383 DOI: 10.1634/Stemcells.2005-0519 |
0.374 |
|
2006 |
Simms-Waldrip T, Hernandez J, Shankar D, Moore TB, Sakamoto KM. 145 TARGETING BCL-2 IN ACUTE MYELOID LEUKEMIA CELLS. Journal of Investigative Medicine. 54: S105.1-S105. DOI: 10.2310/6650.2005.X0004.144 |
0.381 |
|
2006 |
Parcells BW, Ikeda AK, Moore TB, Glaser KB, Sakamoto KM. 138 THE MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITOR ABT-869 INDUCES APOPTOSIS IN BAF3 CELLS EXPRESSING THE FLT3 INTERNAL TANDEM DUPLICATION MUTATION. Journal of Investigative Medicine. 54: S103.5-S104. DOI: 10.2310/6650.2005.X0004.137 |
0.398 |
|
2006 |
Esparza SD, Shankar D, Nelson S, Sakamoto K. Identification of Meis1 as a Target of CREB in Myeloid Leukemogenesis. Blood. 108: 1945-1945. DOI: 10.1182/Blood.V108.11.1945.1945 |
0.448 |
|
2006 |
Cheng JC, Shankar D, Nelson SF, Sakamoto KM. Requirement of CREB in Normal and Malignant Hematopoiesis. Blood. 108: 1168-1168. DOI: 10.1182/Blood.V108.11.1168.1168 |
0.474 |
|
2006 |
Martinez-F F, Jimenez-O FA, Machuca-R C, Villegas-C H, Sakamoto K. 970. Transcriptional Activat ion of krox-1 Induced by Sexual Hormones in Osteosarcoma Cells Molecular Therapy. 13: S373-S374. DOI: 10.1016/J.Ymthe.2006.08.1062 |
0.386 |
|
2005 |
Sakamoto KM. Chimeric molecules to target proteins for ubiquitination and degradation. Methods in Enzymology. 399: 833-47. PMID 16338398 DOI: 10.1016/S0076-6879(05)99054-X |
0.389 |
|
2005 |
Shankar DB, Cheng JC, Sakamoto KM. Role of cyclic AMP response element binding protein in human leukemias. Cancer. 104: 1819-24. PMID 16196046 DOI: 10.1002/cncr.21401 |
0.33 |
|
2005 |
Kinjo K, Sandoval S, Sakamoto KM, Shankar DB. The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle (Georgetown, Tex.). 4: 1134-5. PMID 16096372 DOI: 10.4161/Cc.4.9.1991 |
0.447 |
|
2005 |
Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM, Sakamoto KM. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 7: 351-62. PMID 15837624 DOI: 10.1016/J.Ccr.2005.02.018 |
0.434 |
|
2005 |
Mora-Garcia P, Wei J, Sakamoto KM. G-CSF induces stabilization of ETS protein Fli-1 during myeloid cell development. Pediatric Research. 57: 63-6. PMID 15557108 DOI: 10.1203/01.Pdr.0000147729.55592.2C |
0.433 |
|
2005 |
Menzel LP, Shankar DB, Shah NP, Hummerickhouse R, Hagey A, Sakamoto KM, Moore TB. 156 ANALYSIS OF A TARGETED RECEPTOR TYROSINE KINASE INHIBITOR IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA Journal of Investigative Medicine. 53: S105.1-S105. DOI: 10.2310/6650.2005.00005.155 |
0.43 |
|
2005 |
Kinjo K, Shankar DB, Moore T, Sakamoto KM. 155 THE CYCLIC ADENOSINE MONOPHOSPHATE RESPONSE ELEMENT BINDING PROTEIN REGULATES HEMATOPOIETIC PROGENITOR CELL PROLIFERATION AND MYELOID ENGRAFTMENT Journal of Investigative Medicine. 53: S104.6-S105. DOI: 10.2310/6650.2005.00005.154 |
0.366 |
|
2005 |
Shankar DB, Chang JC, Parcells B, Sandoval S, Li J, Wei R, Tapang P, Davidsen SK, Albert DH, Glaser KB, Moore TB, Sakamoto KM. The Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis of AML Cells Both In Vitro and In Vivo. Blood. 106: 616-616. DOI: 10.1182/Blood.V106.11.616.616 |
0.426 |
|
2005 |
Shankar DB, Kinjo K, Chang J, Sakamoto KM. CREB Transgenic Mice Develop Myeloproliferative Disease/Myelodysplastic Syndrome after a Prolonged Latency. Blood. 106: 367-367. DOI: 10.1182/Blood.V106.11.367.367 |
0.413 |
|
2004 |
Cheng JC, Sakamoto KM. The emerging role of RNA interference in the design of novel therapeutics in oncology. Cell Cycle (Georgetown, Tex.). 3: 1398-401. PMID 15492503 DOI: 10.4161/Cc.3.11.1240 |
0.321 |
|
2004 |
Verma R, Peters NR, D'Onofrio M, Tochtrop GP, Sakamoto KM, Varadan R, Zhang M, Coffino P, Fushman D, Deshaies RJ, King RW. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science (New York, N.Y.). 306: 117-20. PMID 15459393 DOI: 10.1126/Science.1100946 |
0.589 |
|
2004 |
Shankar DB, Sakamoto KM. The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias. Leukemia & Lymphoma. 45: 265-70. PMID 15101710 DOI: 10.1080/1042819031000151095 |
0.415 |
|
2004 |
Schneekloth JS, Fonseca FN, Koldobskiy M, Mandal A, Deshaies R, Sakamoto K, Crews CM. Chemical genetic control of protein levels: selective in vivo targeted degradation. Journal of the American Chemical Society. 126: 3748-54. PMID 15038727 DOI: 10.1021/Ja039025Z |
0.59 |
|
2004 |
Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, Ramaswamy G, Sakamoto KM, Darzynkiewicz Z, Xu M, Dai W. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood. 103: 1278-85. PMID 14576056 DOI: 10.1182/Blood-2003-06-2158 |
0.375 |
|
2004 |
Shankar DB, Landaw EM, Rao N, Moore TB, Sakamoto KM. CREB Is Amplified in AML Blasts and Is Associated with an Increased Risk of Relapse and Decreased Event-Free Survival. Blood. 104: 573-573. DOI: 10.1182/Blood.V104.11.573.573 |
0.401 |
|
2004 |
Kinjo K, Shankar DB, Cheng J, Esparza S, Federman N, Moore TB, Sakamoto KM. CREB Overexpression In Vivo Results in Increased Proliferation, Blast Transformation, and Earlier Engraftment of Myeloid Progenitor Cells. Blood. 104: 3548-3548. DOI: 10.1182/Blood.V104.11.3548.3548 |
0.392 |
|
2004 |
Shankar DB, Kinjo K, Cheng J, Esparza S, Federman N, Moore TB, Sakamoto KM. Cyclin A Is a Target Gene of Activated CREB Downstream of GM-CSF Signaling That Regulates Normal and Malignant Myelopoiesis. Blood. 104: 2181-2181. DOI: 10.1182/Blood.V104.11.2181.2181 |
0.502 |
|
2003 |
Cheng JC, Moore TB, Sakamoto KM. RNA interference and human disease. Molecular Genetics and Metabolism. 80: 121-8. PMID 14567961 DOI: 10.1016/J.Ymgme.2003.08.011 |
0.342 |
|
2003 |
Sakamoto KM, Kim KB, Verma R, Ransick A, Stein B, Crews CM, Deshaies RJ. Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation. Molecular & Cellular Proteomics : McP. 2: 1350-8. PMID 14525958 DOI: 10.1074/Mcp.T300009-Mcp200 |
0.597 |
|
2003 |
Lin M, Chang JK, Shankar D, Sakamoto KM. The role of p55CDC in cell cycle control and mammalian cell proliferation, differentiation, and apoptosis. Experimental and Molecular Pathology. 74: 123-8. PMID 12710943 DOI: 10.1016/S0014-4800(02)00021-7 |
0.444 |
|
2003 |
Mora-Garcia P, Cheng J, Crans-Vargas HN, Countouriotis A, Shankar D, Sakamoto KM. Transcriptional regulators and myelopoiesis: the role of serum response factor and CREB as targets of cytokine signaling. Stem Cells (Dayton, Ohio). 21: 123-30. PMID 12634408 DOI: 10.1634/stemcells.21-2-123 |
0.336 |
|
2002 |
Mora-Garcia P, Pan R, Sakamoto KM. G-CSF regulation of SRE-binding proteins in myeloid cells. Leukemia. 16: 2332-3. PMID 12399981 DOI: 10.1038/Sj.Leu.2402686 |
0.376 |
|
2002 |
Sakamoto KM. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Molecular Genetics and Metabolism. 77: 44-56. PMID 12359129 DOI: 10.1016/S1096-7192(02)00146-4 |
0.359 |
|
2002 |
Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood. 99: 2617-9. PMID 11895805 DOI: 10.1182/Blood.V99.7.2617 |
0.397 |
|
2001 |
Schmid I, Sakamoto KM. Analysis of DNA content and green fluorescent protein expression. Current Protocols in Cytometry / Editorial Board, J. Paul Robinson, Managing Editor ... [Et Al.]. Unit 7.16. PMID 18770728 DOI: 10.1002/0471142956.Cy0716S16 |
0.319 |
|
2001 |
Xu Z, Dziarski R, Wang Q, Swartz K, Sakamoto KM, Gupta D. Bacterial peptidoglycan-induced tnf-alpha transcription is mediated through the transcription factors Egr-1, Elk-1, and NF-kappaB. Journal of Immunology (Baltimore, Md. : 1950). 167: 6975-82. PMID 11739517 DOI: 10.4049/Jimmunol.167.12.6975 |
0.338 |
|
2001 |
Shou W, Sakamoto KM, Keener J, Morimoto KW, Traverso EE, Azzam R, Hoppe GJ, Feldman RM, DeModena J, Moazed D, Charbonneau H, Nomura M, Deshaies RJ. Net1 stimulates RNA polymerase I transcription and regulates nucleolar structure independently of controlling mitotic exit. Molecular Cell. 8: 45-55. PMID 11511359 DOI: 10.1016/S1097-2765(01)00291-X |
0.694 |
|
2001 |
Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proceedings of the National Academy of Sciences of the United States of America. 98: 8554-9. PMID 11438690 DOI: 10.1073/Pnas.141230798 |
0.57 |
|
2001 |
Lin ML, Sakamoto KM. p55Cdc/cdc20 overexpression promotes early g1/s transition in myeloid cells. Stem Cells (Dayton, Ohio). 19: 205-11. PMID 11359945 DOI: 10.1634/Stemcells.19-3-205 |
0.39 |
|
2001 |
Crans HN, Sakamoto KM. Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia. 15: 313-31. PMID 11237053 DOI: 10.1038/Sj.Leu.2402033 |
0.373 |
|
2001 |
Sakamoto K, Deshaies R, Crews C. Protechials: A novel approach to pharmacological inhibition of protein function Nature Genetics. 27: 83-83. DOI: 10.1038/87274 |
0.556 |
|
2000 |
Wu H, Lan Z, Li W, Wu S, Weinstein J, Sakamoto KM, Dai W. p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase. Oncogene. 19: 4557-62. PMID 11030144 DOI: 10.1038/Sj.Onc.1203803 |
0.421 |
|
2000 |
Mora-Garcia P, Sakamoto KM. Granulocyte colony-stimulating factor induces Egr-1 up-regulation through interaction of serum response element-binding proteins. The Journal of Biological Chemistry. 275: 22418-26. PMID 10806199 DOI: 10.1074/Jbc.M001731200 |
0.389 |
|
2000 |
Kwon EM, Raines MA, Blenis J, Sakamoto KM. Granulocyte-macrophage colony-stimulating factor stimulation results in phosphorylation of cAMP response element-binding protein through activation of pp90RSK. Blood. 95: 2552-8. PMID 10753834 DOI: 10.1182/Blood.V95.8.2552.008K30_2552_2558 |
0.379 |
|
1999 |
Chu YW, Wang R, Schmid I, Sakamoto KM. Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry. 36: 333-9. PMID 10404149 DOI: 10.1002/(Sici)1097-0320(19990801)36:4<333::Aid-Cyto8>3.0.Co;2-F |
0.358 |
|
1999 |
Aicher WK, Sakamoto KM, Hack A, Eibel H. Analysis of functional elements in the human Egr-1 gene promoter. Rheumatology International. 18: 207-14. PMID 10399797 DOI: 10.1007/S002960050086 |
0.357 |
|
1999 |
Rolli M, Kotlyarov A, Sakamoto KM, Gaestel M, Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. The Journal of Biological Chemistry. 274: 19559-64. PMID 10391889 DOI: 10.1074/Jbc.274.28.19559 |
0.377 |
|
1999 |
Mora-Garcia P, Sakamoto KM. Cell signaling defects and human disease. Molecular Genetics and Metabolism. 66: 143-71. PMID 10066384 DOI: 10.1006/Mgme.1998.2798 |
0.301 |
|
1998 |
Lin M, Mendoza M, Kane L, Weinstein J, Sakamoto KM. Analysis of cell death in myeloid cells inducibly expressing the cell cycle protein p55Cdc. Experimental Hematology. 26: 1000-6. PMID 9728936 |
0.32 |
|
1998 |
Weinstein J, Karim J, Geschwind DH, Nelson SF, Krumm J, Sakamoto KM. Genomic organization, 5' flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc. Molecular Genetics and Metabolism. 64: 52-7. PMID 9682218 DOI: 10.1006/Mgme.1998.2698 |
0.402 |
|
1997 |
Watanabe S, Kubota H, Sakamoto KM, Arai K. Characterization of cis-acting sequences and trans-acting signals regulating early growth response 1 and c-fos promoters through the granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. Blood. 89: 1197-206. PMID 9028942 DOI: 10.1182/Blood.V89.4.1197 |
0.319 |
|
1997 |
Kwon EM, Raines MA, Sakamoto KM. GM-CSF Induces Phosphorylation of CREB Through Activation of pp90rsk in Myeloid Cells. • 664 Pediatric Research. 41: 113-113. DOI: 10.1203/00006450-199704001-00684 |
0.424 |
|
1996 |
Horie M, Sakamoto KM, Broxmeyer HE. Regulation of egr-1 gene expression by retinoic acid in a human growth factor-dependent cell line International Journal of Hematology. 63: 303-309. PMID 8762813 DOI: 10.1016/0925-5710(96)00451-3 |
0.323 |
|
1996 |
Mignacca R, Lee H, Kwon E, Sakamoto K. Mechanism of transcriptional activation of the immediate early gene Egr- 1 in response to PIXY321 Blood. 88: 848-854. DOI: 10.1182/Blood.V88.3.848.Bloodjournal883848 |
0.4 |
|
1995 |
Wong A, Sakamoto KM. Granulocyte-Macrophage Colony-stimulating Factor Induces the Transcriptional Activation of egr-1 through a Protein Kinase A-independent Signaling Pathway Journal of Biological Chemistry. 270: 30271-30273. PMID 8530445 DOI: 10.1074/Jbc.270.51.30271 |
0.395 |
|
1995 |
Lee HJ, Mignacca RC, Sakamoto KM. Transcriptional activation of egr-1 by granulocyte-macrophage colony-stimulating factor but not interleukin 3 requires phosphorylation of cAMP response element-binding protein (CREB) on serine 133. The Journal of Biological Chemistry. 270: 15979-83. PMID 7608156 DOI: 10.1074/Jbc.270.27.15979 |
0.356 |
|
1994 |
Sakamoto KM, Fraser JK, Lee HJ, Lehman E, Gasson JC. Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Molecular and Cellular Biology. 14: 5975-85. PMID 8065330 DOI: 10.1128/Mcb.14.9.5975 |
0.373 |
|
1991 |
Sakamoto KM, Golde DW, Gasson JC. The biology and clinical applications of granulocyte-macrophage colony-stimulating factor. The Journal of Pediatrics. 118: S17-20. PMID 1999769 DOI: 10.1016/S0022-3476(05)82185-7 |
0.338 |
|
Low-probability matches (unlikely to be authored by this person) |
2002 |
Mendoza MJ, Wang CX, Lin M, Braun J, Sakamoto KM. Fizzy-related RNA expression patterns in mammalian development and cell lines. Molecular Genetics and Metabolism. 76: 363-6. PMID 12208143 DOI: 10.1016/S1096-7192(02)00102-6 |
0.297 |
|
2011 |
Morimoto K, Moore TB, Schiller G, Sakamoto KM. Transplantation for congenital bone marrow failure syndromes. Bone Marrow Research. 2011: 849387. PMID 22046571 DOI: 10.1155/2011/849387 |
0.296 |
|
2001 |
Wong AL, Sakamoto KM, Johnson EE. Differentiating osteomyelitis from bone infarction in sickle cell disease. Pediatric Emergency Care. 17: 60-3; quiz 64. PMID 11265913 DOI: 10.1097/00006565-200102000-00018 |
0.294 |
|
2006 |
Priceman SJ, Kirzner JD, Nary LJ, Morris D, Shankar DB, Sakamoto KM, Medh RD. Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells. Biochemical and Biophysical Research Communications. 344: 491-9. PMID 16630563 DOI: 10.1016/J.Bbrc.2006.03.169 |
0.294 |
|
2010 |
Sakamoto KM, Shimamura A, Davies SM. Congenital disorders of ribosome biogenesis and bone marrow failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: S12-7. PMID 19770060 DOI: 10.1016/J.Bbmt.2009.09.012 |
0.291 |
|
2007 |
Kaneko OF, Cheng J, Sakamoto K. THE CONDITIONAL KNOCKDOWN OF CREB USING CRE-LOX-REGULATED SHRNA. Journal of Investigative Medicine. 55: S93. DOI: 10.1097/00042871-200701010-00110 |
0.289 |
|
2005 |
Federman N, Sakamoto KM. The genetic basis of bone marrow failure syndromes in children. Molecular Genetics and Metabolism. 86: 100-9. PMID 16125992 DOI: 10.1016/J.Ymgme.2005.07.006 |
0.287 |
|
1996 |
Mignacca R, Lee H, Kwon E, Sakamoto K. Mechanism of transcriptional activation of the immediate early gene Egr- 1 in response to PIXY321 Blood. 88: 848-854. DOI: 10.1182/blood.v88.3.848.bloodjournal883848 |
0.285 |
|
2020 |
Wojcicki AV, Kadapakkam M, Frymoyer A, Lacayo N, Chae HD, Sakamoto KM. Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers. 12. PMID 32069925 DOI: 10.3390/Cancers12020441 |
0.285 |
|
2014 |
Reiss UM, Schwartz J, Sakamoto KM, Puthenveetil G, Ogawa M, Bedrosian CL, Ware RE. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria. Pediatric Blood & Cancer. 61: 1544-50. PMID 24777716 DOI: 10.1182/Blood.V118.21.1034.1034 |
0.285 |
|
2020 |
Smith SM, Sabnis HS, Williamson Lewis R, Effinger KE, Bergsagel DJ, Patterson B, Mertens AC, Sakamoto K, Schapira L, Castellino SM. Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors. Journal of Clinical Oncology. 38: e22527-e22527. DOI: 10.1200/Jco.2020.38.15_Suppl.E22527 |
0.285 |
|
2007 |
Lin TL, Fu C, Sakamoto KM. Cancer stem cells: the root of the problem. Pediatric Research. 62: 239. PMID 17712286 DOI: 10.1203/Pdr.0B013E3181515124 |
0.273 |
|
2021 |
Youn M, Gomez JO, Mark K, Sakamoto KM. RSK Isoforms in Acute Myeloid Leukemia. Biomedicines. 9. PMID 34202904 DOI: 10.3390/biomedicines9070726 |
0.272 |
|
2023 |
Wilkes MC, Chae HD, Scanlon V, Cepika AM, Wentworth EP, Saxena M, Eskin A, Chen Z, Glader B, Roncarolo MG, Nelson SF, Sakamoto KM. SATB1 chromatin loops regulate Megakaryocyte/Erythroid Progenitor Expansion by facilitating HSP70 and GATA1 induction. Stem Cells (Dayton, Ohio). PMID 36987811 DOI: 10.1093/stmcls/sxad025 |
0.271 |
|
2022 |
Ayyadurai VAS, Deonikar P, McLure KG, Sakamoto KM. Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment. Cancers. 14. PMID 35159023 DOI: 10.3390/cancers14030756 |
0.271 |
|
2008 |
Danilova N, Sakamoto KM, Lin S. Role of p53 family in birth defects: lessons from zebrafish. Birth Defects Research. Part C, Embryo Today : Reviews. 84: 215-27. PMID 18773461 DOI: 10.1002/Bdrc.20129 |
0.27 |
|
2004 |
Countouriotis A, Landaw EM, Naeim F, Moore TB, Sakamoto KM. Comparison of bone marrow aspirates and biopsies in pediatric patients with ALL at days 7 and 14 of induction therapy. Leukemia & Lymphoma. 45: 745-7. PMID 15160950 DOI: 10.1080/10428190310001625863 |
0.267 |
|
2000 |
Chu YW, Korb J, Sakamoto KM. Idiopathic thrombocytopenic purpura. Pediatrics in Review / American Academy of Pediatrics. 21: 95-104. PMID 10702324 DOI: 10.1542/Pir.21-3-95 |
0.263 |
|
2013 |
Chang VY, Basso G, Sakamoto KM, Nelson SF. Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia. Bmc Cancer. 13: 55. PMID 23379653 DOI: 10.1186/1471-2407-13-55 |
0.262 |
|
2007 |
Cheng JC, Horwitz EM, Karsten SL, Shoemaker L, Kornblum HI, Malik P, Sakamoto KM. Report on the workshop "New Technologies in Stem Cell Research," Society for Pediatric Research, San Francisco, California, April 29, 2006. Stem Cells (Dayton, Ohio). 25: 1070-88. PMID 17255523 DOI: 10.1634/Stemcells.2006-0397 |
0.252 |
|
2004 |
Sakamoto KM. Knocking down human disease: potential uses of RNA interference in research and gene therapy. Pediatric Research. 55: 912-3. PMID 15103016 DOI: 10.1203/01.Pdr.0000128976.10389.94 |
0.252 |
|
2000 |
Vu PK, Sakamoto KM. Ubiquitin-mediated proteolysis and human disease. Molecular Genetics and Metabolism. 71: 261-6. PMID 11001820 DOI: 10.1006/Mgme.2000.3058 |
0.249 |
|
2018 |
Sakamoto KM, Narla A. Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome. Leukemia. 32: 249-251. PMID 29182601 DOI: 10.1038/Leu.2017.314 |
0.243 |
|
2017 |
Theruvath AJ, Ilivitzki A, Muehe A, Theruvath J, Gulaka P, Kim C, Luna-Fineman S, Sakamoto KM, Yeom KW, Yang P, Moseley M, Chan F, Daldrup-Link HE. A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study. Radiology. 170073. PMID 28777701 DOI: 10.1148/Radiol.2017170073 |
0.237 |
|
2004 |
Cheng JC, Esparza SD, Knez VM, Sakamoto KM, Moore TB. Severe lactic acidosis in a 14-year-old female with metastatic undifferentiated carcinoma of unknown primary. Journal of Pediatric Hematology/Oncology. 26: 780-2. PMID 15543020 DOI: 10.1097/00043426-200411000-00021 |
0.236 |
|
2014 |
Sakamoto KM. Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia. Leukemia & Lymphoma. 55: 1449-50. PMID 24206095 DOI: 10.3109/10428194.2013.862244 |
0.235 |
|
2020 |
Abecasis M, Cross NCP, Brito M, Ferreira I, Sakamoto KM, Hijiya N, Score J, Gale RP. Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia. Leukemia. PMID 32632094 DOI: 10.1038/S41375-020-0957-Z |
0.233 |
|
2006 |
Sandoval S, Sakamoto K, Deepa S. Acceleration of Leukemogenesis in CREB Transgenic Mice by Retroviral Insertional Mutagenesis. Blood. 108: 4895-4895. DOI: 10.1182/Blood.V108.11.4895.4895 |
0.232 |
|
1992 |
Sakamoto K, Erdreich-Epstein A, deClerck Y, Coates T. Prolonged Clinical Response to Vincristine Treatment in Two Patients with Idiopathic Hypereosinophilic Syndrome Pediatric Infectious Disease Journal. 14: 348-351. DOI: 10.1097/00006454-199211000-00012 |
0.232 |
|
2021 |
Wilkes MC, Shibuya A, Sakamoto KM. Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development. Genes. 12. PMID 34681039 DOI: 10.3390/genes12101646 |
0.232 |
|
2009 |
Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM. Corrigendum to "The aggresome pathway as a target for therapy in hematologic malignancies" [Mol. Genet. Metab. 94 (2008) 283-286] (DOI:10.1016/j.ymgme.2008.03.012) Molecular Genetics and Metabolism. 97: 164. DOI: 10.1016/J.Ymgme.2009.04.008 |
0.23 |
|
2021 |
Wilkes MC, Jung K, Lee BE, Saxena M, Sathianathen RS, Mercado JD, Perez C, Flygare J, Narla A, Glader B, Sakamoto KM. The active component of Ginseng, Ginsenoside Rb1, improves erythropoiesis in models of Diamond Blackfan Anemia by targeting Nemo-like Kinase. The Journal of Biological Chemistry. 100988. PMID 34298020 DOI: 10.1016/j.jbc.2021.100988 |
0.229 |
|
1999 |
Hsu H, Rainov N, Sun F, Sakamoto K, Spear M. 2036 Radiation-induced 4-ipomeanol (4-IM) toxicity in cells expressing a transgene fusion protein of cytochrome CYP4B1 and GFP under the control of the EGR1 promoter International Journal of Radiation Oncology*Biology*Physics. 45: 296. DOI: 10.1016/S0360-3016(99)90306-1 |
0.225 |
|
2021 |
Duault C, Kumar A, Taghi Khani A, Lee SJ, Yang L, Huang M, Hurtz C, Manning B, Ghoda LY, McDonald T, Lacayo NJ, Sakamoto KM, Carroll MP, Tasian SK, Marcucci G, et al. Activated Natural Killer Cells Predict Poor Clinical Prognosis in High-risk B- and T- cell Acute Lymphoblastic Leukemia. Blood. PMID 34077953 DOI: 10.1182/blood.2020009871 |
0.215 |
|
2011 |
Frugé E, Lakoski JM, Luban N, Lipton JM, Poplack DG, Hagey A, Felgenhauer J, Hilden J, Margolin J, Vaiselbuh SR, Sakamoto KM. Increasing diversity in pediatric hematology/oncology. Pediatric Blood & Cancer. 57: 147-52. PMID 21284078 DOI: 10.1002/Pbc.22977 |
0.213 |
|
2022 |
Wilkes MC, Scanlon V, Shibuya A, Celika AM, Eskin A, Chen Z, Narla A, Glader B, Roncarolo MG, Nelson SF, Sakamoto KM. Downregulation of SATB1 by miRNAs Reduces Megakaryocyte/Erythroid Progenitor Expansion in pre-clinical models of Diamond Blackfan Anemia. Experimental Hematology. PMID 35460833 DOI: 10.1016/j.exphem.2022.04.005 |
0.212 |
|
2023 |
Sinha R, Dvorak M, Ganesan A, Kalesinskas L, Niemeyer CM, Flotho C, Sakamoto KM, Lacayo N, Patil RV, Perriman R, Cepika AM, Liu YL, Kuo A, Utz PJ, Khatri P, et al. Epigenetic Profiling of Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape. Cancers. 15. PMID 37958378 DOI: 10.3390/cancers15215204 |
0.205 |
|
1992 |
Sakamoto KM, Gasson JC. Clinical applications of human granulocyte-macrophage colony-stimulating factor. International Journal of Cell Cloning. 9: 531-41. PMID 1770227 DOI: 10.1002/Stem.5530090603 |
0.205 |
|
2006 |
Sakamoto KM. Academic training pathways in pediatric hematology-oncology. Pediatric Blood & Cancer. 47: 239-41. PMID 16276524 DOI: 10.1002/Pbc.20671 |
0.204 |
|
2022 |
Liu YL, Shibuya A, Glader B, Wilkes MC, Barna M, Sakamoto KM. Animal models of Diamond-Blackfan anemia: updates and challenges. Haematologica. PMID 36384250 DOI: 10.3324/haematol.2022.282042 |
0.203 |
|
2020 |
Ding YY, Ramakrishna S, Long AH, Phillips CA, Montiel-Esparza R, Diorio CJ, Bailey LC, Maude SL, Aplenc R, Batra V, Reilly AF, Rheingold SR, Lacayo NJ, Sakamoto KM, Hunger SP. Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic. Pediatric Blood & Cancer. e28427. PMID 32588960 DOI: 10.1002/Pbc.28427 |
0.201 |
|
2015 |
Klenk C, Gawande R, Tran VT, Trinh J, Chi K, Owen D, Luna-Fineman S, Sakamoto KM, McMillan A, Quon A, Daldrup-Link HE. Progressing towards a cohesive pediatric 18F-FDG PET/MR protocol: Is the administration of Gadolinium-Chelates necessary? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26471690 DOI: 10.2967/Jnumed.115.161646 |
0.197 |
|
2023 |
Kumar A, Taghi Khani A, Duault C, Aramburo S, Sanchez Ortiz A, Lee SJ, Chan A, McDonald T, Huang M, Lacayo NJ, Sakamoto KM, Yu J, Hurtz C, Carroll M, Tasian SK, et al. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia. Journal For Immunotherapy of Cancer. 11. PMID 37217248 DOI: 10.1136/jitc-2022-006649 |
0.192 |
|
2012 |
Sakamoto K. Preface: special issue on critical reviews in leukemogenesis. Critical Reviews in Oncogenesis. 16: 1. PMID 22150302 DOI: 10.1615/Critrevoncog.V16.I1-2.10 |
0.191 |
|
2002 |
Countouriotis A, Moore TB, Sakamoto KM. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells (Dayton, Ohio). 20: 215-29. PMID 12004080 DOI: 10.1634/stemcells.20-3-215 |
0.187 |
|
2016 |
Zweidler-McKay PA, Hogan MS, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, et al. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer. PMID 27295503 DOI: 10.1002/Pbc.26094 |
0.186 |
|
2021 |
Heitzeneder S, Bosse KR, Zhu Z, Zhelev D, Majzner RG, Radosevich MT, Dhingra S, Sotillo E, Buongervino S, Pascual-Pasto G, Garrigan E, Xu P, Huang J, Salzer B, Delaidelli A, ... ... Sakamoto K, et al. GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. Cancer Cell. PMID 34971569 DOI: 10.1016/j.ccell.2021.12.005 |
0.184 |
|
2009 |
Rodriguez-Gonzalez A, Sakamoto KM. Proteolysis targeting chimeric molecules recruiting cancer-causing proteins for ubiquitination and degradation Modulation of Protein Stability in Cancer Therapy. 147-160. DOI: 10.1007/978-0-387-69147-3_9 |
0.178 |
|
2009 |
Sakamoto KM, Dipple KM. Becoming a woman physician scientist. Academic Medicine : Journal of the Association of American Medical Colleges. 84: 817. PMID 19550165 DOI: 10.1097/Acm.0B013E3181A85849 |
0.171 |
|
2022 |
Zhang K, Horikoshi N, Li S, Powers AS, Hameedi MA, Pintilie GD, Chae HD, Khan YA, Suomivuori CM, Dror RO, Sakamoto KM, Chiu W, Wakatsuki S. Cryo-EM, Protein Engineering, and Simulation Enable the Development of Peptide Therapeutics against Acute Myeloid Leukemia. Acs Central Science. 8: 214-222. PMID 35233453 DOI: 10.1021/acscentsci.1c01090 |
0.169 |
|
2021 |
Youn M, Smith SM, Lee AG, Chae HD, Spiteri E, Erdmann J, Galperin I, Jones LM, Donato M, Abidi P, Bittencourt H, Lacayo N, Dahl G, Aftandilian C, Davis KL, ... ... Sakamoto KM, et al. Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. Cancers. 13. PMID 34944883 DOI: 10.3390/cancers13246263 |
0.16 |
|
2005 |
Moore TB, Sakamoto KM. Topics in pediatric leukemia--hematopoietic stem cell transplantation. Medgenmed : Medscape General Medicine. 7: 19. PMID 16369324 |
0.143 |
|
2005 |
Moore TB, Sakamoto KM. Topics in pediatric leukemia - Hematopoietic stem cell transplantation Medgenmed Medscape General Medicine. 7. |
0.143 |
|
2021 |
Smith SM, Sabnis HS, Lewis RW, Effinger KE, Bergsagel J, Patterson B, Mertens A, Sakamoto KM, Schapira L, Castellino SM. Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias. Bmc Cancer. 21: 474. PMID 33926411 DOI: 10.1186/s12885-021-08182-z |
0.137 |
|
2009 |
Sakamoto KM, Frank DA. CREB in the pathophysiology of cancer: Implications for targeting transcription factors for cancer therapy (Clinical Cancer Research (2009) 15 (2583-2587)) Clinical Cancer Research. 15: 3643. DOI: 10.1158/1078-0432.CCR-15-10-COR1 |
0.121 |
|
2001 |
Sakamoto KM. Semaxanib (SUGEN). Idrugs : the Investigational Drugs Journal. 4: 1061-7. PMID 15965852 |
0.12 |
|
2001 |
Sakamoto KM. Semaxanib sugen Idrugs. 4: 1061-1067. |
0.12 |
|
2022 |
Lo YC, Keyes TJ, Jager A, Sarno J, Domizi P, Majeti R, Sakamoto KM, Lacayo N, Mullighan CG, Waters J, Sahaf B, Bendall SC, Davis KL. CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors. Nature Communications. 13: 934. PMID 35177627 DOI: 10.1038/s41467-022-28484-5 |
0.108 |
|
2005 |
Cheng J, Sakamoto KM. Topics in pediatric leukemia - Acute myeloid leukemia Medgenmed Medscape General Medicine. 7. |
0.106 |
|
2005 |
Esparza SD, Sakamoto KM. Topics in pediatric leukemia--acute lymphoblastic leukemia. Medgenmed : Medscape General Medicine. 7: 23. PMID 16369328 |
0.1 |
|
2005 |
Esparza SD, Sakamoto KM. Topics in pediatric leukemia - Acute lymphoblastic leukemia Medgenmed Medscape General Medicine. 7. |
0.1 |
|
2023 |
Natarajan A, Fremin BJ, Schmidtke DT, Wolfe MK, Zlitni S, Graham KE, Brooks EF, Severyn CJ, Sakamoto KM, Lacayo NJ, Kuersten S, Koble J, Caves G, Kaplan I, Singh U, et al. The Tomato Brown Rugose Fruit Virus Movement Protein Gene Is a Novel Microbial Source Tracking Marker. Applied and Environmental Microbiology. e0058323. PMID 37404180 DOI: 10.1128/aem.00583-23 |
0.099 |
|
2022 |
Reschke A, Richards RM, Smith SM, Long AH, Marks LJ, Schultz L, Kamens JL, Aftandilian C, Davis KL, Gruber T, Sakamoto KM. Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Frontiers in Oncology. 12: 1033993. PMID 36523979 DOI: 10.3389/fonc.2022.1033993 |
0.095 |
|
2021 |
Smith SM, Hijiya N, Sakamoto KM. Chronic Myelogenous Leukemia in Childhood. Current Oncology Reports. 23: 40. PMID 33718985 DOI: 10.1007/s11912-021-01025-x |
0.092 |
|
2023 |
Natarajan A, Fremin BJ, Schmidtke DT, Wolfe MK, Zlitni S, Graham KE, Brooks EF, Severyn CJ, Sakamoto KM, Lacayo NJ, Kuersten S, Koble J, Caves G, Kaplan I, Singh U, et al. Tomato brown rugose fruit virus Mo gene is a novel microbial source tracking marker. Biorxiv : the Preprint Server For Biology. PMID 36712100 DOI: 10.1101/2023.01.09.523366 |
0.09 |
|
2022 |
Tal A, Moerdler S, Fernández CR, Dome JS, Sakamoto KM. Can you hear me now? Tools for cultivating a culture of respect, value, and appreciation within pediatric hematology, oncology, and cellular therapy. Pediatric Blood & Cancer. e30127. PMID 36495252 DOI: 10.1002/pbc.30127 |
0.089 |
|
1996 |
Kwon EM, Sakamoto KM. The molecular mechanism of action of granulocyte-macrophage colony-stimulating factor. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 44: 442-6. PMID 8952224 |
0.088 |
|
2005 |
Casillas J, Sakamoto KM. Topics in pediatric leukemia--acute lymphoblastic leukemia and late effects in long-term survivors. Medgenmed : Medscape General Medicine. 7: 22. PMID 16369327 |
0.086 |
|
2005 |
Casillas J, Sakamoto KM. Topics in pediatric leukemia - Acute lymphoblastic leukemia and late effects in long term survivors Medgenmed Medscape General Medicine. 7. |
0.086 |
|
2005 |
Federman N, Sakamoto KM. Topics in pediatric leukemia--Fanconi's anemia: new insights. Medgenmed : Medscape General Medicine. 7: 23. PMID 16369402 |
0.084 |
|
2024 |
Menger JM, Sathianathen RS, Sakamoto KM, Hijiya N. BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach. Current Oncology Reports. 26: 250-257. PMID 38340217 DOI: 10.1007/s11912-024-01502-z |
0.082 |
|
2021 |
Smith SM, Zhang S, Sundaram V, Roth M, Andolina JR, Schapira L, Sakamoto KM, Kolb EA, Hijiya N, Chaudhury S. Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatric Hematology and Oncology. 1-15. PMID 34918996 DOI: 10.1080/08880018.2021.2017085 |
0.079 |
|
2003 |
Hsu H, Rainov NG, Quinones A, Eling DJ, Sakamoto KM, Spear MA. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Research. 23: 2723-8. PMID 12894565 |
0.078 |
|
2022 |
Ford M, Mauro M, Aftandilian C, Sakamoto KM, Hijiya N. Management of Chronic Myeloid Leukemia in Children and Young Adults. Current Hematologic Malignancy Reports. PMID 35920965 DOI: 10.1007/s11899-022-00673-5 |
0.073 |
|
2002 |
Sakamoto KM. Targeting ubiquitinylation for drug discovery. Idrugs : the Investigational Drugs Journal. 5: 779-81. PMID 14686374 |
0.069 |
|
2002 |
Sakamoto KM. Targeting Ubiquitinylation for Drug Discovery: 24-25 June 2002, San Diego, CA, USA Idrugs. 5: 779-781. |
0.051 |
|
2005 |
Lasky J, Sakamoto KM. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood. Medgenmed : Medscape General Medicine. 7: 21. PMID 16369326 |
0.05 |
|
2005 |
Lasky J, Sakamoto KM. Topics in pediatric leukemia - Myelodysplastic and myeloproliferative disorders of childhood Medgenmed Medscape General Medicine. 7. |
0.05 |
|
2013 |
Palmer PI, Parrington M, Lee JD, Lewis AC, Rickard AR, Bernath PF, Duck TJ, Waugh DL, Tarasick DW, Andrews S, Aruffo E, Bailey LJ, Barrett E, Bauguitte JBS, Curry KR, ... ... Sakamoto KM, et al. Quantifying the impact of BOReal forest fires on Tropospheric oxidants over the Atlantic using Aircraft and Satellites (BORTAS) experiment: Design, execution and science overview Atmospheric Chemistry and Physics. 13: 6239-6261. DOI: 10.5194/Acp-13-6239-2013 |
0.047 |
|
2014 |
Franklin JE, Drummond JR, Griffin D, Pierce JR, Waugh DL, Palmer PI, Parrington M, Lee JD, Lewis AC, Rickard AR, Taylor JW, Allan JD, Coe H, Walker KA, Chisholm L, ... ... Sakamoto KM, et al. A case study of aerosol scavenging in a biomass burning plume over eastern Canada during the 2011 BORTAS field experiment Atmospheric Chemistry and Physics. 14: 8449-8460. DOI: 10.5194/Acp-14-8449-2014 |
0.044 |
|
2001 |
Sakamoto KM. Onogenomics: dissecting cancer through genome research. Idrugs : the Investigational Drugs Journal. 4: 392-3. PMID 16015473 |
0.044 |
|
2000 |
Murakawa Y, Takase K, Sakamoto K, Suesoshi M, Nagatomo H. Characterization of a Lentogenic Newcastle Disease Virus Isolated from Broiler Chickens in Japan Avian Diseases. 44: 686. DOI: 10.2307/1593112 |
0.017 |
|
2007 |
Fu CH, Sakamoto KM. PEG-asparaginase. Expert Opinion On Pharmacotherapy. 8: 1977-84. PMID 17696798 DOI: 10.1517/14656566.8.12.1977 |
0.015 |
|
2009 |
Sakamoto K. Balancing work and life: an interview with Kathleen Sakamoto. Stem Cells (Dayton, Ohio). 27: 2053-5. PMID 19676122 DOI: 10.1002/stem.195 |
0.012 |
|
2015 |
Sakamoto KM, Allan JD, Coe H, Taylor JW, Duck TJ, Pierce JR. Aged boreal biomass-burning aerosol size distributions from BORTAS 2011 Atmospheric Chemistry and Physics. 15: 1633-1646. DOI: 10.5194/acp-15-1633-2015 |
0.01 |
|
2012 |
Aftandilian CC, Milotich C, Sakamoto KM. The neutropenic diet... still ageless? Oncology (Williston Park, N.Y.). 26: 586, 588-9. PMID 22870544 |
0.01 |
|
2012 |
Aftandilian CC, Milotich C, Sakamoto KM. The neutropenic diet.... Still ageless? Oncology (United States). 26. |
0.01 |
|
2004 |
Sakamoto KM. Su-11248 Sugen. Current Opinion in Investigational Drugs (London, England : 2000). 5: 1329-39. PMID 15648955 |
0.01 |
|
Hide low-probability matches. |